Translocation of glomerular p47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy

Diabetes

Volumn 52, Issue 10, 2003, Pages 2603-2614

  Kitada, Munehiro ^b   Koya, Daisuke ^b   Sugimoto, Toshiro ^b   Isono, Motohide ^b   Araki, Shin Ichi ^b   Kashiwagi, Atsunori ^b   Haneda, Masakazu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADENOVIRUS VECTOR; CELL PROTEIN; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; PROTEIN P47PHOX; PROTEIN P67PHOX; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RUBOXISTAURIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULUS; GLUCOSE BLOOD LEVEL; KIDNEY INJURY; MALE; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; DEOXYGUANOSINE; DIABETIC NEPHROPATHIES; ENZYME ACTIVATION; ENZYME INHIBITORS; INDOLES; ISOENZYMES; KIDNEY GLOMERULUS; MALE; MALEIMIDES; MEMBRANES; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; STAINING AND LABELING;

EID: 0141755311     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.10.2603     Document Type: Article

References (53)

1. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445, 1996
2. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hirai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H: New biomarker evidence of DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150-152, 1997
3. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications. Diabetes 48:1-9, 1999
4. Ha H, Kim C, Son Y, Chung MH, Kim KH: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 16:271-274, 1994
5. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effect of ACEI and ARB. Kidney Int 61:186-194, 2002
6. Melhem MF, Craven PA, Derubertis FR: Effect of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124-133, 2001
7. Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 8:426-435, 1997
8. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK: Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8:1405-1414, 1997
9. Keyse SM, Tyrrell RM: Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A 86:99-103, 1989
10. Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, Kikkawa R: Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract 52:85-96, 2001
11. Williamson JR, Chang K, Fragos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
12. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
13. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945, 2000
14. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG: Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271:H1626-H1634, 1996
15. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM Callis GM, Quinn MT: Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94:14483-14488, 1997
16. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS: Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274:19814-19822, 1999
17. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KG, Lambeth D: Cell transformation by the superoxide-generating oxidase Mox 1. Nature 401:79-82, 1999
18. Jones SA, Hancock JT, Jones OTG, Neubauer A, Topley N: The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 5:1483-1491, 1995
19. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, Pavenstadt H: NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 53:654-663, 1998
20. Shiose A, Kurodai J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakai Y, Sumitomo HA: Novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276:1417-1423, 2001
21. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK: Novel gp91 (phox): homologues in vascular smooth muscle cells: nox-1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894, 2001
22. Babior BM: NADPH oxidase: An update. Blood 93:1464-1476, 1999
23. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase Cβ isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
24. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Bursell SE, Kem TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 22:728-731, 1996
25. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Ameriolation of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447, 2000
26. Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R: Thiazolidinedione compounds ameliorate glomerular dysfunction independent of insulin-sensitizing action in diabetic rats. Diabetes 49:1022-1032, 2000
27. Eisei N, Akihide N, Koji U, Hirokazu T, Minoru O, Toshiro F, Sergey B, Michael SG: Oxidative and nitrosative stress in acute renal ischenua. Am J Physiol 281:F948-F957, 2001
28. Kashiwagi A, Shinozaki K, Nishio Y, Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hidaka H, Yasuda H, Kikkawa R: Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 277:E976-E983, 1999
29. Bayraktutan U, Blayney L, Shah AM: Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 20:1903-1911, 2000
30. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G: Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300-305, 2002
31. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiler-Kleiner D, Drexler H: Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ Res 87:1195-1201, 2000
32. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-274, 2002
33. Wakasald H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL: Targeted overexpression of protein kinase C β2 isoform in myocardium cayses cardiomyopathy. Proc Natl Acad Sci U S A 94:9320-9325, 1997
34. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
35. Kaneto H, Suzuma K, Sharma A, Bonner-Weir S, King GL, Weir GC: Involvement of protein kinase C β2 in c-myc induction by high glucose in pancreatic β-cells. J Biol Chem 277:3680-3685, 2002
36. Benov L, Sztejnberg L, Fridovich I: Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25:826-831, 1998
37. Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A 86:9697-9701, 1989
38. Li Y, Zhu H, Kuppusamy P, Rouband V, Zweier JL, Trush MA: Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 273:2015-2023, 1998
39. Li JM, Shah AM: Differential NADPH-versus NADH-dependent: superoxide production by phagocyte-type endothelial cell NADPH oxidase. Cardiovasc Res 52:477-486, 2001
40. Griedling KK, Minieri CA, Ollerenshaw JD Alexander RW: Angioteltsin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
41. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54:775-784, 1998
42. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK: Tumor necrosis factor-α activates a p22phox-based NADH oxidase in vascular smooth muscle cells. Biochem J 329:653-657, 1998
43. 2: generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J Biol Chem 270:30334-30338, 1995
44. 2 for platelet-derived growth factor signal transduction. Science 270:296-299, 1995
45. Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR: Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 272:C421-C427, 1997
46. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK: Oscillatory and laminar shear stress differentially affect human endothelial redox state. Circ Res 82:1094-1101, 1998
47. Fukui T, Ishizuka N, Rajagopalan S, Laursen JB, Capers QIV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK: p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45-51, 1997
48. Kim YK, Lee MS, Son SM, Kim IJ, Lee WS, Rhim BY, Hong KW, Kim CD: Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51:522-527, 2002
49. Cifuentes ME, Rey FE, Carretero OA, Pagano PJ: Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice. Am J Physiol 279:H2234-H2240, 2000
50. Dekker LV, Leitges M, Altschuler G, Mistry N, Mcdermott A, Roes J, Segal AW: Protein kinase C-β contributes to NADPH oxidase activation in neutrophils. Biochem J 347:285-289, 2000
51. Yamamori T, Inanami O, Nagahata H, Cui YD, Kuwabara M: Roles of p38 MAPK, PKC and PI3-K in the signaling pathways of NADPH oxidase activation and phagocytosis in bovine polymorphonuclear leukocytes. FEBS Lett 467:253-258, 2000
52. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK: Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91:406-413, 2002
53. Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J: Phosphorylation of p47phox site by PKC α, βII, δ, and ζ: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41:7743-7750, 2002